| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 89 | 9.130 | 9.230 | 10.199 | 13.955 | 13.296 | 15.486 | 18.094 | 18.575 |
| Total Income - EUR | - | 89 | 9.758 | 9.230 | 10.199 | 13.955 | 13.296 | 15.486 | 18.094 | 18.575 |
| Total Expenses - EUR | - | 0 | 4.882 | 5.107 | 5.445 | 5.723 | 5.772 | 6.702 | 10.585 | 13.486 |
| Gross Profit/Loss - EUR | - | 89 | 4.876 | 4.123 | 4.754 | 8.231 | 7.525 | 8.784 | 7.509 | 5.090 |
| Net Profit/Loss - EUR | - | 86 | 4.784 | 4.030 | 4.653 | 8.092 | 7.392 | 8.629 | 7.355 | 4.904 |
| Employees | - | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioart Innovation S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 134 | 6.025 | 4.602 | 5.176 | 8.647 | 10.404 | 12.614 | 12.983 | 14.183 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 89 | 832 | 4.514 | 5.090 | 8.564 | 10.293 | 11.254 | 9.228 | 10.576 |
| Cash | - | 45 | 5.194 | 88 | 86 | 83 | 111 | 1.360 | 3.756 | 3.607 |
| Shareholders Funds | - | 131 | 4.913 | 4.161 | 4.703 | 8.141 | 9.895 | 12.167 | 12.409 | 13.425 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3 | 1.112 | 441 | 473 | 505 | 509 | 447 | 574 | 758 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6203 - 6203" | |||||||||
| CAEN Financial Year |
6203
|
|||||||||
Comments - Bioart Innovation S.r.l.